ZA200705119B - Matrix type sustained-release preparation containing basic drug or salt thereof, and method for manufacturing the same - Google Patents

Matrix type sustained-release preparation containing basic drug or salt thereof, and method for manufacturing the same

Info

Publication number
ZA200705119B
ZA200705119B ZA200705119A ZA200705119A ZA200705119B ZA 200705119 B ZA200705119 B ZA 200705119B ZA 200705119 A ZA200705119 A ZA 200705119A ZA 200705119 A ZA200705119 A ZA 200705119A ZA 200705119 B ZA200705119 B ZA 200705119B
Authority
ZA
South Africa
Prior art keywords
salt
manufacturing
same
matrix type
preparation containing
Prior art date
Application number
ZA200705119A
Inventor
Ueki Yosuke
Fujioka Satoshi
Original Assignee
Eisai R&D Man Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai R&D Man Co Ltd filed Critical Eisai R&D Man Co Ltd
Publication of ZA200705119B publication Critical patent/ZA200705119B/en

Links

ZA200705119A 2004-12-27 2007-06-18 Matrix type sustained-release preparation containing basic drug or salt thereof, and method for manufacturing the same ZA200705119B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2004376770 2004-12-27

Publications (1)

Publication Number Publication Date
ZA200705119B true ZA200705119B (en) 2008-06-25

Family

ID=38943724

Family Applications (2)

Application Number Title Priority Date Filing Date
ZA200705118A ZA200705118B (en) 2004-12-27 2007-06-18 Method for stabilizing anti-dementia drug
ZA200705119A ZA200705119B (en) 2004-12-27 2007-06-18 Matrix type sustained-release preparation containing basic drug or salt thereof, and method for manufacturing the same

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ZA200705118A ZA200705118B (en) 2004-12-27 2007-06-18 Method for stabilizing anti-dementia drug

Country Status (2)

Country Link
CN (2) CN101090738A (en)
ZA (2) ZA200705118B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102309465B (en) * 2010-06-30 2015-04-22 天津药物研究院 Sustained release tablet containing donepezil hydrochloride active component as well as preparation method and application thereof
WO2013078608A1 (en) 2011-11-29 2013-06-06 Ziqiang Gu Donepezil pamoate and methods of making and using the same
CN103315974B (en) * 2012-03-22 2016-05-25 成都康弘药业集团股份有限公司 Osmotic pump type controlled release preparation that contains donepezil and salt thereof and preparation method thereof
WO2014132218A1 (en) * 2013-02-28 2014-09-04 Lupin Limited Pharmaceutical compositions of donepezil having specific in vitro dissolution profile or pharmacokinetics parameters
CN103393614B (en) * 2013-07-03 2016-01-27 丽珠集团丽珠制药厂 A kind of Perospirone Hydrochloride slow releasing preparation and preparation method
CN105334206B (en) * 2014-08-17 2019-07-02 山西振东安特生物制药有限公司 A kind of dissolution determination method containing colloid pectin bismuth preparation
CN106176659B (en) * 2015-05-05 2019-07-12 四川科瑞德制药股份有限公司 A kind of Tandospirone enteric coatel tablets and preparation method thereof
CN113350291B (en) * 2020-03-04 2024-08-23 广东东阳光药业股份有限公司 Composition of acetylcholinesterase inhibitor and preparation method thereof
CN114129541B (en) * 2022-01-05 2023-05-30 南通联亚药业股份有限公司 Diltiazem hydrochloride sustained-release capsule and preparation method and application thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1175813C (en) * 2002-02-07 2004-11-17 王志刚 Donepezil hydrochloride dripping pills
CN1270717C (en) * 2003-11-28 2006-08-23 李思成 Galantamin sustained release preparation and preparing process

Also Published As

Publication number Publication date
CN101090737A (en) 2007-12-19
ZA200705118B (en) 2008-09-25
CN101090738A (en) 2007-12-19
CN101090737B (en) 2010-09-08

Similar Documents

Publication Publication Date Title
IL183871A0 (en) Matrix type sustained-release preparation containing basic drug or salt thereof, and method for manufacturing the same
ZA200705119B (en) Matrix type sustained-release preparation containing basic drug or salt thereof, and method for manufacturing the same
IL177087A0 (en) Controlled-release pharmaceutical composition and method for producing the same
HUS1400056I1 (en) Glucopyranosyl-substituted benzol derivatives, drugs containing said compounds, the use thereof and method for the production thereof
HK1103393A1 (en) Cyclohexane derivative, prodrug thereof and salt thereof, and therapeutic agent containing the same for diabetes
IL181012A0 (en) Substituted 8-aminoalkoxi-xanthines, method for the production thereof and use thereof as medicaments
PL378065A1 (en) Substituted n-arylheterocycles, method for production and use thereof as medicaments
HK1167332A1 (en) Pharmaceutical composition, use thereof and method for making the same
IL187713A0 (en) 3-aminocarbazole compounds, pharmaceutical composition containing the same and method for the preparation thereof
IL180397A0 (en) Diamine derivatives, fungicidal compositions containing the same, and processes for the preparation thereof
SI1767526T1 (en) Arylamidine derivative, salt thereof and antifungal containing these
HK1082909A1 (en) Controlled-release drug composition
IL228730A0 (en) Pharmaceutical manufacturing process
EP1731139A4 (en) S/o type pharmaceutical preparation and process for producing the same
IL184314A0 (en) Substituted 4-phenyltetrahydroisoquinolines, methods for producing them, their use as drug, and drug containing them
IL178887A0 (en) Novel beta agonists, method for producing the same and their use as drugs
PL394600A1 (en) Vinylazocycloalkanyl compound, process for the preparation thereof, its use and pharmaceutical composition
ZA200601001B (en) Substituted thienoimidazoles, method for production and use thereof as medicament or diagnostic and medicament comprising the same
HK1100946A1 (en) 1-a-HALO-2,2-DIFLUORO-2-DEOXY-D-RIBOFURANOSE DERIVATIVES AND PROCESS FOR THE PREPARATION THEREOF
GB2401043B (en) Drug
EP1669087A4 (en) Preparation containing basic drug
EP1781678A4 (en) 1-alpha-halo-2,2-difluoro-2-deoxy-d-ribofuranose derivatives and process for the preparation thereof
IL175293A0 (en) Pharmaceutical formulation containing an ltb4 antagonist, method for the production thereof, and use thereof
EP1954689A4 (en) N-substituted-1h-quinoline-2, 4-diones, preparation method thereof, and pharmaceutical composition containing the same
EP1693067A4 (en) Pharmaceutical anti-herpetic composition, method for producing a dosage form based thereon and method for the use thereof